Researchers at the University of Oxford, the Francis Crick Institute and University College London have been granted £1.7 million of funding from Cancer Research UK and the CRIS Cancer Foundation to develop a lung cancer vaccine. The team are seeking to create ‘LungVax’, the world’s first vaccine to prevent lung cancer in people with a high risk of the disease. From COVID-19 breakthrough to lung cancer vaccine The LungVax vaccine will use technology similar to the highly successful Oxford/AstraZeneca COVID-19 vaccine. In the same way traditional vaccines use part…
Read More£1.7 million for the world’s first vaccine to prevent lung cancer
